New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Iwona Rzeszutek und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Flavonols, Mitochondria, Cellular Senescence. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.
Abstract (Originalsprache)
Mitochondria are considered as promising targets for cancer treatment. In the present study, triphenyl phosphonium cationic group-conjugated fisetin (mito-fisetin) was synthesized, and its anticancer activity was investigated in several cellular models of estrogen receptor (ER)-positive breast cancer in vitro and in vivo in proliferating and tamoxifen-promoted senescent states. Mito-fisetin, when used at low micromolar concentrations, stimulated the dissipation of mitochondrial membrane potential and oxidative stress, and affected mitochondrial function, resulting in apoptosis induction in senescent breast cancer cells. Mito-fisetin-mediated cytotoxicity was due to increased levels of phosphorylated AMPK, decreased levels of AKT and HSP90, and impaired mitophagic response, as judged by the analysis of the markers of mitophagosome formation. Senescent breast cancer cells were found to be more sensitive to mito-fisetin treatment than proliferating ones. We postulate that mitochondrial targeting in the case of fisetin may be considered as a promising anticancer and senotherapeutic strategy to eliminate drug-resistant senescent breast cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Pigonia 1, 35-310 Rzeszow, Poland.
- Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.
- Department of Biochemistry and Molecular Biology, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
ORCID-Profile: Maciej Wnuk, Joanna Kałafut, Grzegorz Litwinienko, Anna Lewińska
Förderung
- Narodowe Centrum Nauki
Zitieren
APA
Rzeszutek, I., Cybularczyk-Cecotka, M., Deręgowska, A., Stec, P., Wnuk, M., Kołodziej, O., Kałafut, J., Wawruszak, A., Witkowski, W., Litwinienko, G., & Lewińska, A. (2024). New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01664
Vancouver
Rzeszutek I, Cybularczyk-Cecotka M, Deręgowska A, Stec P, Wnuk M, Kołodziej O, et al. New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01664
BibTeX
@article{Rzeszutek2024,
author = {Rzeszutek, Iwona and Cybularczyk-Cecotka, Martyna and Deręgowska, Anna and Stec, Paulina and Wnuk, Maciej and Kołodziej, Olga and Kałafut, Joanna and Wawruszak, Anna and Witkowski, Wojciech and Litwinienko, Grzegorz and Lewińska, Anna},
title = {New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer Cells},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01664}
}
EUVIMED